This meeting took place in 2015


Here are the related meetings in 2020:
Noncoding RNAs: Mechanism, Function and Therapies (A1)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

MicroRNAs and Noncoding RNAs in Cancer (E5)


Organizer(s) Frank J. Slack, Manel Esteller and Lin He
June 7—12, 2015
Keystone Resort • Keystone, Colorado USA
Discounted Abstract Deadline: Feb 5, 2015
Abstract Deadline: Mar 5, 2015
Scholarship Deadline: Feb 5, 2015
Discounted Registration Deadline: Apr 7, 2015

Sponsored by Journal of Molecular Cell Biology (JMCB) and Merck & Co., Inc.

Summary of Meeting:
MicroRNAs and other noncoding RNAs have recently emerged as key regulators of gene expression during development and are frequently mis-expressed in human disease states, in particular cancer. MicroRNAs act to promote or repress cell proliferation, migration and apoptosis during development, all processes that go awry in cancer. Thus, microRNAs have the ability to behave like oncogenes or tumor suppressors. Their small size and molecular properties make microRNAs amenable as targets and therapeutics in cancer treatment. MicroRNAs thus present a paradigm shift in thinking about gene regulation during development and disease and provide the oncologist with a potentially powerful new battery of agents to diagnose and treat cancer. However, while hundreds of human microRNAs and noncoding RNAs are known, relatively little is known about their roles and targets, and there is still a limited literature on using these molecules in the clinic. The specific aims of this meeting serve to address these deficiencies and are as follows: 1) Focus on the exciting biology of microRNAs and noncoding RNAs in controlling developmental and cancer processes like cell proliferation, differentiation, cell cycle, apoptosis and metastasis. This meeting will highlight the best current research into the role that miRNAs play in these fundamental processes and provide the basic understanding that will drive the invention of powerful clinical tools; 2) Focus on the latest efforts to harness the power of these RNAs as agents in the fight against cancer. Discussions will range from use of miRNAs as diagnostic and prognostic markers in cancer, to SNPs providing risk factors for cancer, to the delivery and effectiveness of small RNA therapeutics in clinically relevant settings; 3) Attract the best researchers working in small RNAs and cancer to one place for critical discussions that will advance the field and accelerate the benchside to bedside use of this technology; and 4) Provide a stimulating environment where students, postdocs and junior investigators can present and discuss their research with the best minds in the field.

View Meeting Program

Scholarships/Awards

National Cancer Institute (NCI) Scholarship Recipients

Xiying Fan
University of Colorado Boulder, USA

Yejing Ge
Rockefeller University, USA

Zhiji Ren
University of Massachusetts Medical School, USA

The Barrie Hesp Scholarship on behalf of Ashley Rebecca Cukier Scholarship Recipients

Katrien Van Roosbroeck
University of Texas MD Anderson Cancer Center, USA

The Elkes Foundation Scholarship Recipients

Vanessa Mondol
Yale University, USA

Molly A. Taylor
AstraZeneca, UK

Quan Zhu
The Salk Institute of Biological Studies, USA